These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 25747927)
41. Frontiers in addiction research: celebrating the 35th anniversary of the National Institute on Drug Abuse. Sponsor's foreword. Shurtleff D; Liu R; Sasek C Neuropharmacology; 2009; 56 Suppl 1():1-2. PubMed ID: 18789343 [No Abstract] [Full Text] [Related]
42. Network-assisted prediction of potential drugs for addiction. Sun J; Huang LC; Xu H; Zhao Z Biomed Res Int; 2014; 2014():258784. PubMed ID: 24689033 [TBL] [Abstract][Full Text] [Related]
43. The Experience and Effectiveness of Nurse Practitioners in Orthopaedic Settings: A Comprehensive Systematic Review. Taylor A; Staruchowicz L JBI Libr Syst Rev; 2012; 10(42 Suppl):1-22. PubMed ID: 27820153 [TBL] [Abstract][Full Text] [Related]
44. Quality assurance of research protocols conducted in the community: the National Institute on Drug Abuse Clinical Trials Network experience. Rosa C; Campbell A; Kleppinger C; Sampson R; Tyson C; Mamay-Gentilin S Clin Trials; 2009 Apr; 6(2):151-61. PubMed ID: 19342468 [TBL] [Abstract][Full Text] [Related]
45. The anatomy of medical research: US and international comparisons. Moses H; Matheson DH; Cairns-Smith S; George BP; Palisch C; Dorsey ER JAMA; 2015 Jan; 313(2):174-89. PubMed ID: 25585329 [TBL] [Abstract][Full Text] [Related]
46. Maximizing Effectiveness Trials in PTSD and SUD Through Secondary Analysis: Benefits and Limitations Using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" Study as a Case Example. Hien DA; Campbell AN; Ruglass LM; Saavedra L; Mathews AG; Kiriakos G; Morgan-Lopez A J Subst Abuse Treat; 2015 Sep; 56():23-33. PubMed ID: 25907849 [TBL] [Abstract][Full Text] [Related]
47. Contributions of mobile technologies to addiction research. Swendsen J Dialogues Clin Neurosci; 2016 Jun; 18(2):213-21. PubMed ID: 27489461 [TBL] [Abstract][Full Text] [Related]
48. Addiction research centres and the nurturing of creativity: The Swiss Institute for the Prevention of Alcohol and Drug Problems. Past, present and future. Kuntsche E; Maffli E; Kuntsche S; Delgrande Jordan M Addiction; 2009 May; 104(5):699-704. PubMed ID: 19413784 [TBL] [Abstract][Full Text] [Related]
49. NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. Berman JW; Carson MJ; Chang L; Cox BM; Fox HS; Gonzalez RG; Hanson GR; Hauser KF; Ho WZ; Hong JS; Major EO; Maragos WF; Masliah E; McArthur JC; Miller DB; Nath A; O'Callaghan JP; Persidsky Y; Power C; Rogers TJ; Royal W J Neuroimmune Pharmacol; 2006 Dec; 1(4):351-99. PubMed ID: 18040811 [TBL] [Abstract][Full Text] [Related]
50. Nonhuman animal models of substance use disorders: Translational value and utility to basic science. Smith MA Drug Alcohol Depend; 2020 Jan; 206():107733. PubMed ID: 31790978 [TBL] [Abstract][Full Text] [Related]
51. Two birds with one stone: experiences of combining clinical and research training in addiction medicine. Klimas J; McNeil R; Ahamad K; Mead A; Rieb L; Cullen W; Wood E; Small W BMC Med Educ; 2017 Jan; 17(1):22. PubMed ID: 28114925 [TBL] [Abstract][Full Text] [Related]
52. Addiction Research Centres and the Nurturing of Creativity. Substance abuse research in a modern health care centre: the case of the Centre for Addiction and Mental Health. Rehm J; Giesbrecht N; Gliksman L; Graham K; Le AD; Mann RE; Room R; Rush B; Tyndale RF; Wells S Addiction; 2011 Apr; 106(4):689-97. PubMed ID: 20491727 [TBL] [Abstract][Full Text] [Related]
53. National Institute on Drug Abuse's behavioral research agenda. Leshner AI Exp Clin Psychopharmacol; 2000 Aug; 8(3):273-5. PubMed ID: 10975616 [TBL] [Abstract][Full Text] [Related]
54. A centralized informatics infrastructure for the National Institute on Drug Abuse Clinical Trials Network. Pan JJ; Nahm M; Wakim P; Cushing C; Poole L; Tai B; Pieper CF Clin Trials; 2009 Feb; 6(1):67-75. PubMed ID: 19254937 [TBL] [Abstract][Full Text] [Related]
55. Building global capacity for brain and nervous system disorders research. Cottler LB; Zunt J; Weiss B; Kamal AK; Vaddiparti K Nature; 2015 Nov; 527(7578):S207-13. PubMed ID: 26580329 [TBL] [Abstract][Full Text] [Related]
56. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network. Marsch LA; Campbell A; Campbell C; Chen CH; Ertin E; Ghitza U; Lambert-Harris C; Hassanpour S; Holtyn AF; Hser YI; Jacobs P; Klausner JD; Lemley S; Kotz D; Meier A; McLeman B; McNeely J; Mishra V; Mooney L; Nunes E; Stafylis C; Stanger C; Saunders E; Subramaniam G; Young S J Subst Abuse Treat; 2020 Mar; 112S():4-11. PubMed ID: 32220409 [TBL] [Abstract][Full Text] [Related]
57. Substance use disorder approaches in US primary care clinics with national reputations as workforce innovators. O'Malley DM; Abraham CM; Lee HS; Rubinstein EB; Howard J; Hudson SV; Kieber-Emmons AM; Crabtree BF Fam Pract; 2022 Mar; 39(2):282-291. PubMed ID: 34423366 [TBL] [Abstract][Full Text] [Related]
58. The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment. Tai B; Straus MM; Liu D; Sparenborg S; Jackson R; McCarty D J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S4-13. PubMed ID: 20307794 [TBL] [Abstract][Full Text] [Related]
59. Preliminary Results and Publication Impact of a Dedicated Addiction Clinician Scientist Research Fellowship. Klimas J; Fernandes E; deBeck K; Hayashi K; Milloy MJ; Kerr T; Cullen W; Wood E J Addict Med; 2017; 11(1):80-81. PubMed ID: 28157832 [No Abstract] [Full Text] [Related]
60. Review of the application of positive psychology to substance use, addiction, and recovery research. Krentzman AR Psychol Addict Behav; 2013 Mar; 27(1):151-65. PubMed ID: 22985057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]